GGrantIndex
Sort

82,697 grants matching vaccine development

General Clinical Research Center

$7,246,894
Richard D Krugman · University Of Colorado Denver · M01 · FY2007 · RR

Consortia for Innovative AIDS Research in Nonhuman Primates

$7,245,181
Dan H. Barouch · Beth Israel Deaconess Medical Center · UM1 · FY2016 · AI

Units for HIV/AIDS Clinical Trials Networks

$7,238,931
Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · U01 · FY2010 · AI

Pacific NorthWest Regional Center of Excellence (PNWRCE)

$7,230,475
Jay A Nelson · Oregon Health & Science University · U54 · FY2013 · AI

Center for Research in Diagnostics and Discovery

$7,228,229
W. Ian Lipkin · Columbia University Health Sciences · U19 · FY2016 · AI

Southeast Regional Centers of Excellence for Biodefense & Emerging Infectious Di

$7,226,237
Philip Frederick Sparling · Univ Of North Carolina Chapel Hill · U54 · FY2013 · AI

Core C: Structure, Computational, Protein Engineering

$7,225,891
Richard J. Kuhn · Washington University · U19 · FY2024 · AI

HIV Preventive Vaccine and Monoclonal Antibody Studies

$7,211,045
Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

The Baltimore Longitudinal Study of Aging

$7,185,421
Eleanor M Simonsick · National Institute On Aging · ZIA · FY2025 · AG

Preclinical Evaluation of Envelope Immunogens Optimized to Elicit VRCOI-class An

$7,178,959
Leonidas A Stamatatos · Fred Hutchinson Cancer Research Center · U19 · FY2015 · AI

Consortium for Immunotherapeutics against Emerging Viral Threats

$7,168,390
Erica Ollmann Saphire · La Jolla Institute For Immunology · U19 · FY2019 · AI

Dengue Human Immunology Project Consortium (DHIPC)

$7,165,769
Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2016 · AI

DCTD Biopharmaceutical Development

$7,145,669
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2018 · CA

Consortium for Immunotherapeutics against Emerging Viral Threats

$7,143,424
Erica Ollmann Saphire · La Jolla Institute For Immunology · U19 · FY2020 · AI

Pandemic Preparedness: Biocontainment Facility Upgrade and Integration at UTMB/Galveston National Laboratory

$7,131,815
Gary Kobinger · University Of Texas Med Br Galveston · G20 · FY2022 · AI

REGIONAL PRIMATE RESEARCH CENTER SUPPORT

$7,131,463
University Of Wisconsin Madison · P51 · FY2001 · RR

Leadership for HIV/AIDS Clinical Trials Networks; Microbicide Trials Network

$7,116,100
Benoit Masse · Fred Hutchinson Cancer Research Center · U01 · FY2008 · AI

Rocky Mountain Regional Center of Excellence or Biodefense and Emerging Infectiou

$7,102,851
John T Belisle · Colorado State University · U54 · FY2012 · AI

Einstein BSL3 Laboratory Renovation to Advance Biomedical Research on RNA Viruses of Pandemic Potential

$7,100,728
Kartik Chandran · Albert Einstein College Of Medicine · G20 · FY2022 · AI

Units for HIV/AIDS Clinical Trials Networks

$7,098,824
Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · U01 · FY2011 · AI

Task V05: Development of Assays and Reagents for Coronavirus Vaccines

$7,094,023
Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2020 · AI

NIAID VRC NUCLEIC ACID AND LIPID TECHNOLOGY DEVELOPMENT

$7,090,787
Victoria Coleman · Leidos Biomedical Research, Inc. · N01 · FY2023 · AI

GYNECOLOGIC ONCOLOGY GROUP

$7,085,529
American College Of Ob And Gyn · U10 · FY2000 · CA

The Southwest National Primate Research Center

$7,069,521
Kenneth Parkhurst Trevett · Texas Biomedical Research Institute · P51 · FY2013 · OD

Consortium for Immunotherapeutics against Emerging Viral Threats

$7,065,330
Erica Ollmann Saphire · La Jolla Institute For Immunology · U19 · FY2021 · AI